Unihealth Hospitals Ltd (UNIHEALTH) — shareholding pattern, promoter holding, financials and share price
About Unihealth Hospitals Ltd (UNIHEALTH)
Unihealth Hospitals Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as UNIHEALTH and on the BSE under scrip code 91654. Its ISIN is INE0PRF01011.
Incorporated in 2010, Unihealth Consultancy Ltd is in the business of Medical Tour Operator and Health Consultancy Service & Trader in Medical Equipments [1]
UniHealth Hospitals Limited is a healthcare service provider operating medical centers, hospitals, and consultancy services across India and Africa. It is engaged in medical value travel, enhancing patient access to advanced medical care.
The company reported significant financial growth with revenues rising to ₹66.67 Cr in H1 FY26, and a notable improvement in EBITDA margin to 49.76%, reflecting enhanced operational efficiency.
Listed peers in Hospital: Shalby Ltd, GPT Healthcare Ltd, Gujarat Kidney & Super Speciality Ltd, KRM Ayurveda Ltd, Asarfi Hospital Ltd, Hannah Joseph Hospital Ltd.
Valuation & Returns
10 Jul 2026At ₹709.95 a share on 10 Jul 2026, Unihealth Hospitals Ltd (UNIHEALTH) was valued at a price-to-earnings ratio of 43.7x against an industry P/E of 61.73x and a price-to-book of 8.11x on a book value of ₹87.5 per share. Solomo computes return on equity of 18.77% and return on capital employed of 27.73% from filed results.
- P/E
- 43.7x
- Industry P/E
- 61.73x
- P/B
- 8.11x
- EPS (TTM)
- ₹16.52
- Book value / share
- ₹87.5
- ROE
- 18.77%
- ROCE
- 27.73%
- ROA
- 17.88%
- Debt / equity
- 0.27x
- Dividend yield
- 0%
- EBITDA margin
- 44.56%
- 52-week range
- ₹133.65 – ₹747.9
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Unihealth Hospitals Ltd (UNIHEALTH) reported revenue of ₹132 crore, net profit of ₹46 crore and earnings per share of ₹16.45. That compares with revenue of ₹99 crore and net profit of ₹27 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹65 crore and net profit ₹17 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 37 | 44 | 49 | 99 | 132 |
| Net profit (₹ cr) | 4 | 8 | 10 | 27 | 46 |
| EPS (₹) | - | - | - | - | 16.45 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 38.17% | 44.30% | 33.23% |
| Profit growth | 55.80% | 81.06% | 67.59% |
| Stock price CAGR | - | - | 320% |
Ownership Summary
Sep 2025As of Sep 2025, promoters hold 69.14% of Unihealth Hospitals Ltd (UNIHEALTH). Market capitalisation was ₹1,129 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2023.
Largest disclosed public shareholders in Sep 2025: MUKESH SHARMA 2.15%, ANANT WEALTH CONSULTANTS 1.96%, THERMO CAPITAL PRIVATE LIMITED 1.73%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Sep 2025 | 69.14% | - | - | - | - |
| Mar 2025 | 68.93% | - | - | - | - |
| Sep 2024 | 68.93% | - | - | - | - |
| Mar 2024 | 68.8% | - | - | - | - |
| Sep 2023 | 68.8% | - | - | - | - |